Company: SQFTP
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001437749-25-010185
Chunk: 236

Company: Presidio Property Trust, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 9
Chunk 236
---
) and public common stock warrants (CDTTW) presented on the consolidated balance sheets were measured at fair value using Level 1 market prices, taking into account the adoption of ASU 2022-03, Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions, and totaled approximately $0.2 million as of  December 31, 2024. The combined value of our Investment in Conduit Pharmaceuticals marketable securities, including the Private CDT Warrants, totaled $0.2 million as of  December 31, 2024. Our investments in Conduit's common stock and public common stock warrants presented on the consolidated balance sheet were measured at fair value using Level 1 market prices as of  December 31, 2023, and totaled approximately $18.3 million.  The adjustments to the fair value of our investment in Conduit Pharmaceuticals marketable securities are recorded in net loss in Conduit Pharmaceuticals marketable securities on our consolidated statement of operations.

        F-
       14

   The following table presents as of  December 31, 2024 the Company’s assets subject to measurement at fair value on a nonrecurring basis (in thousands):

       Fair Value Measurements as of December 31, 2024  
   Level 1    Level 2    Level 3    Total    Impairment Loss  
 Assets:                     
 Goodwill for Dubose Model Homes  $-  $-  $1,123,000  $1,123,000  $- 
 Goodwill for NTR Property Management   -   -   266,000   266,000   185,000 
 Certain Real Estate assets   -   -   18,065,871   18,065,871   1,784,311 
 Total Assets  $-  $-  $19,454,871  $19,454,871  $1,969,311 

   The following table presents as of  December 31, 2023 the Company’s assets subject to measurement at fair value on a nonrecurring basis (in thousands):

       Fair Value Measurements as of December 31, 2023      
   Level 1    Level 2    Level 3